LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jan 9, 2018
Finance
Stars in China
Biotech winners, losers in 4Q17
Read More
BioCentury
|
Dec 8, 2017
Clinical News
AbbVie planning risankizumab submissions in psoriasis
Read More
BioCentury
|
Dec 5, 2017
Clinical News
AbbVie planning risankizumab submissions in psoriasis
Read More
BioCentury
|
Oct 27, 2017
Clinical News
AbbVie reports Phase III psoriasis data for IL-23 mAb risankizumab
Read More
BioCentury
|
Oct 26, 2017
Clinical News
AbbVie reports Phase III psoriasis data for IL-23 mAb
Read More
BioCentury
|
Oct 3, 2016
Top Story
J&J's guselkumab tops Humira in Phase III psoriasis trial
Read More
BioCentury
|
Jul 25, 2016
Regulation
Salvage in psoriasis?
Why brodalumab fills a small but important niche in psoriasis
Read More
BioCentury
|
May 5, 2016
Clinical News
Sun's anti-IL23 mAb meets in Phase III psoriasis trials
Read More
BioCentury
|
Mar 14, 2016
Company News
Boehringer Ingelheim, AbbVie deal
Read More
BioCentury
|
Mar 14, 2016
Product Development
The missing piece
How AbbVie's Boehringer deal advances its Humira replacement strategy
Read More
Items per page:
10
1 - 10 of 12
Username
Elevio by Dixa